Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype

Microvascular Research

Volumn 75, Issue 2, 2008, Pages 155-168

  Buchwalter, A ^a   Van Dort, C ^a   Schultz, S ^a   Smith, R ^a   Le, I P ^a   Abbott, J L ^a   Oosterhouse, E ^a   Johnson, A E ^a   Hansen Smith, F ^b   Burnatowska Hledin, M ^a  

^a HOPE COLLEGE   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Actin; Cellular proliferation; egr 1; Nedd8

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; MASPIN; UNCLASSIFIED DRUG; VASOPRESSIN ACTIVATED CALCIUM MOBILIZING RECEPTOR; VASOPRESSIN RECEPTOR;

ACTIN POLYMERIZATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; IN VITRO STUDY; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL PROLIFERATION; CELL SHAPE; CERCOPITHECUS AETHIOPS; COS CELLS; CULLIN PROTEINS; CYCLIC AMP; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL CELLS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, ANIMAL; MUSCLE, SKELETAL; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SERPINS; TRANSFECTION; UBIQUITINS;

RATTUS;

EID: 39049127959     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.08.004     Document Type: Article

References (53)

1. Arai T.J., Kasper S., Skaar J.R., Ali S.H., Takahashi C., and DeCaprio J.A. Targeted disruption of p185/cul7 gene results in abnormal vascular morphogenesis. Proc. Natl. Acad. Sci. 100 (2003) 9855-9860
2. Bass R., Moreno-Fernandez A.M., and Ellis V. Maspin inhibits cell migration in absence of protease inhibitory activity. J. Biol. Chem. 277 (2000) 46845-46848
3. Beck Jr. K.L., and D'Amore P.A. Vascular development: cellular and molecular regulation. FASEB J. 11 (1997) 365-373
4. Blacque O., and Worrall M. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. 277 (2001) 10783-10788
5. Burnatowska-Hledin M., Spielman W.S., Smith W.L., Shi P., Meyer J.M., and Dewitt D.L. Expression cloning of an AVP-activated calcium-mobilizing receptor from rabbit kidney medulla. Am. J. Physiol. 268 (1995) F1198-F1210
6. Burnatowska-Hledin M., Lazdins I.B., Listenberger L., Zhao P., Sharangpani A.M., Folta V., and Card B. VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule. Am. J. Physiol. 276 (1999) F199-F209
7. Burnatowska-Hledin M., Capps B., Folta V., Zhao P., Mungall C., Sharangpani A.M., and Listenberger L. VACM-1 a cullin gene family member, regulates cellular signaling. Am. J. Physiol. 279 (2000) 1266-1273
8. Burnatowska-Hledin M., Zeneberg A., Roulo A., Grobe J., Zhao P., Lelkes P.L., Clare P., and Barney C. Expression of VACM-1 protein in cultured rat adrenal endothelial cells is linked to the cell cycle. Endothelium 8 (2001) 49-63
9. Burnatowska-Hledin M., Kossoris J., Van Dort C., Murrey D., Abbott J., Kan C., and Barney C. VACM-1 expression in T47D human breast cancer cell line. Biochem. Biophys. Res. Commun. 319 (2004) 817-825
10. Byrd P.J., Stankovic T., McConville C.M., Smith A.D., Cooper P.R., and Taylor A.M.R. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res. 7 (1997) 71-75
11. Calderwood D.A., Shattil S.J., and Ginsberg M.H. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J. Biol. Chem. 275 (2000) 22607-22610
12. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 (1993) 14553-14556
13. Dusbery N., Resau J., Webb C., Koochekpour S., Koo H.M., Leppla S.H., and Vande Woude G.F. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc. Natl. Acad. Sci. 98 (2001) 4089-4094
14. Folkman J., and Haudenschild C. Angiogenesis in vitro. Nature 288 (1980) 551-556
15. Glickman M.H., and Ciechanover A. The ubiquitin-proteosome proteolitic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2001) 373-428
16. Hansen-Smith F., Banker K., Morris L., and Joswiak G. Alternative histochemical markers for skeletal muscle capillaries: a statistical comparison among three muscles. Microvasc. Res. 44 (1992) 112-116
17. Herrmann J., Ciechanover A., Lerman L.O., and Lerman A. The ubiquitin-proteosome system in cardiovascular diseases-a hypothesis extended. Cardiovasc. Res. 61 (2004) 11-21
18. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 329 (1987) 219-222
19. Hori T., Osaka F., Miyamoto C., Okabayashi K., Shimbara N., Kato S., and Tanaka K. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 18 (1999) 6829-6834
20. Johnson A.E., Le I.P., Buchwalter A., and Burnatowska-Hledin M.A. Estrogen dependent growth and estrogen receptor (ER)-α concentration in T47D breast cancer cells are inhibited by VACM-1, a cul-5 Gene. Mol. Cell. Biochem. 301 (2007) 13-20
21. Kaufmann K., Bach K., and Thiel G. The extracellular signal-regulated protein kinases Erk1/Erk2 stimulate expression and biological activity of the transcriptional regulator Egr-1. J. Biol. Chem. 382 (2001) 1077-1081
22. Keydar I., Chen L., Karby S., Weiss F.R., Delarea J., Radu M., Chaitcik S., and Brenner H.J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15 (1979) 659-670
23. Khachigian L., and Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ. Res. 81 (1997) 457-461
24. Kipreos E.T., Lander L.E., Wing J.P., He W.W., and Hedgecock E.M. Cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 85 (1996) 829-839
25. Kurz T.L., Pintard J.H., Willis D.R., Hamill P., Gonczy M.P., and Bowerman B. Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification pathway. Science 295 (2002) 1294-1298
26. Lagna G., and Hemmati-Brivanlou A. Use of dominant negative constructs to modulated gene expression. Curr. Top. Dev. Biol. 36 (1998) 74-98
27. Lyapina S.A., Correll C.C., Kipreos E.T., and Deshaies R.J. Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein. Proc. Natl. Acad. Sci. 95 (1998) 7451-7456
28. 1- to S-phase transition and identifies a conserved family of proteins. Mol. Cell. Biol. 16 (1996) 6634-6643
29. Mukhopadhyay D., Knebelmann B., Cohen H.T., Ananth S., and Sukhatme V.P. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to suppress vascular endothelial growth factor promoter activity. Mol. Cell. Biol. 17 (1997) 5629-5639
30. Odero-Marah V.A., Khalkhali-Ellis Z., Chunthapong J., Amir S., Seftor R.E.B., Seftor E.A., and Hendrix M.J.C. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol. Ther. 2 (2003) e67-e72
31. Ou C.-Y., Lin Y.-F., Chen Y.-J., and Chien C.-T. Distinct protein degradation mechanisms mediated by Cu1 and Cul3 controlling Ci stability in Drosophila eye development. Genes Dev. 16 (2002) 2403-2414
32. Pan Z.-Q., Kentsis A., Dias D.C., Yamoah K., and Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23 (2004) 1985-1997
33. Papadimitriou E., Unsworth B.R., Maragoudakis M.E., and Lelkes P.I. Time-course and quantification of extracellular matrix maturation in the chick chorioallantoic membrane and in cultured endothelial cells. Endothelium 1 (1993) 207-219
34. Papetti M., and Herman I.M. Mechanism of normal and tumor-derived angiogenesis. Am. J. Physiol. 282 (2002) C946-C970
35. Pause A., Lee S., Worrell R.A., Chen D.Y.T., Burgess W.H., Linehan W.M., and Klausner R.D. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. 94 (1997) 2156-2161
36. Qian Y., Luo J., Leonard S.S., Harris G.K., Millecchia L., Flynn D.D.C., and Shi X. Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesis. J. Biol. Chem. 278 (2003) 16189-16197
37. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., and Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullin-containing complex. Genes Dev. 15 (2001) 3104-3117
38. Rozenghurt E., Legg A., Strang G., and Courtenay-Luck N. Cyclic AMP: a mitogenic signal for Swiss 3T3 cells. Proc. Natl. Acad. Sci. 78 (1981) 4392-4396
39. Rupprecht H., Sukhatme V., Rupprecht A., Sterzel R., and Coleman D. Serum response elements mediate protein kinase C dependent transcriptional induction of early growth response gene-1 by arginine vasopressin in rat mesangial cells. J. Cell. Physiol. 159 (1994) 311-323
40. Senger D.R., Van De Water L., Brown L.F., Nagy J.A., Yeo K.T., Yeo T.K., Berse B., Jackman R.W., Dvorak A.M., and Dvorak H.F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12 (1993) 303-324
41. Tsunematsu R., Nakayama K., Oike Y., Nishiyama M., Ishida N., Hatakeyama S., Bessho Y., Kageyama R., Suda T., and Nakayama K. Mouse Fbw7/Sel-10/Cdc4 is required for Notch degradation during vascular development. J. Biol. Chem. 279 (2004) 9417-9423
42. Usatyuk P., and Natarajan V.V. Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J. Biol. Chem. 279 (2004) 11789-11797
43. Van Dort C., Zhao P., Parmelee K., Capps B., Poel A., Listenberger L., Wasilevich B., Murrey J.D., Kossoris J., Clare P., and Burnatowska-Hledin M. VACM-1, a cullin gene family member, attenuates cellular growth in vitro. Am. J. Physiol. 285 (2003) C1386-C1396
44. Wada H., Yeh E.T.H., and Kamitani T. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J. Biol. Chem. 275 (2000) 17008-17015
45. Wickstroom S.A., Alitalo K., and Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278 (2003) 37895-37901
46. Wimuttisuk W., and Singer J.D. The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer. Mol. Biol. Cell 18 (2007) 899-909
47. Wormald S., and Hilton D.J. Inhibitors of cytokine signal transduction. J. Biol. Chem. 279 (2003) 821-824
48. Wu K., Chen A., and Pan Z.-Q. Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquity polymerization. J. Biol. Chem. 275: 41 (2000) 32317-32324
49. Wu Y.-L., Hooks S.B., Harden T.K., and Dohlman H.G. Dominant-negative inhibition of pheromone receptor signaling by a single point mutation in the G protein a subunit. J. Biol. Chem. 279 (2004) 35287-35297
50. Yancopoulos G.D., Klagsbrun M., and Folkman J. Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the boarder. Cell 93 (1998) 661-664
51. Yu H., Peters J.M., King R.W., Page A.M., Hieter P., and Kirschner M.W. Identification of a cullin homology region in a subunit of the anaphase-promoting complex. Science 279 (1998) 1219-1222
52. Yu X.Y.Y., Liu B., Luo K., Kong W., and Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 (2003) 1056-1060
53. Zou Z., Anisowicz A., Hendrix M.J.C., Thor A., Neveu M., Sheng S., Rafidi K., Seftor E., and Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263 (1994) 526-529